APIs (Active Pharmaceutical Ingredients)

We are proud to announce the establishment of our advanced API (Active Pharmaceutical Ingredient) manufacturing facility, equipped to produce a broad range of high-quality molecules. It has successfully been audited by EU Qualified Person (QP), and received approvals from the Drug Controller General of India (DCGI) and the Central Drugs Standard Control Organization (CDSCO) India. Our facility is currently focused on the production of multi-compendial Ofloxacin and is actively developing additional molecules in the Quinolone segment. We are in the process of obtaining Certificate of Suitability (CEP) for our quinolone products in the coming months, enabling us to expand into the European market. API Products: OFLOXACIN - IP/BP/USP/EP CIPROFLOXACIN - IP/BP/USP/EP MOXIIFLOXACIN - IP/BP/USP/EP NORFLOXACIN - IP/BP/USP/EP GATIFLOXACIN - IP/BP/USP LEVOFLOXACIN - IP/BP/USP/EP